Literature DB >> 9638475

The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions.

J S Hayflick1, P Kilgannon, W M Gallatin.   

Abstract

Macromolecular adhesive associations between cells are important for transmitting spatial and temporal information that is critical for immune system function. One such group of proteins, the intercellular adhesion molecules (ICAMs), has grown as newly identified members are revealed. In addition, the functions of the ICAMs, in general, have begun to be better understood, including intracellular signaling events. This information has led to the design of novel therapeutic agents that may prove effective in a variety of disease states.

Mesh:

Substances:

Year:  1998        PMID: 9638475     DOI: 10.1007/BF02786454

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  95 in total

1.  Expression of ICAM-3 on human epidermal dendritic cells.

Authors:  M J Staquet; J Peguet; C Jacquet; C Dezutter-Dambuyant; D Schmitt
Journal:  Immunobiology       Date:  1995-02       Impact factor: 3.144

2.  The LW blood group glycoprotein is homologous to intercellular adhesion molecules.

Authors:  P Bailly; P Hermand; I Callebaut; H H Sonneborn; S Khamlichi; J P Mornon; J P Cartron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 3.  The T lymphocyte antigen receptor--paradigm lost.

Authors:  J C Jensenius; A F Williams
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

4.  Engagement of the T-cell antigen receptor by anti-CD3 monoclonal antibody causes a rapid increase in lymphocyte F-actin.

Authors:  P D Phatak; C H Packman
Journal:  J Cell Physiol       Date:  1994-05       Impact factor: 6.384

5.  A physical map of two clusters containing the genes for six proinflammatory receptors.

Authors:  V Alvarez; E Coto; F Setién; C López-Larrea
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses.

Authors:  N Patey; R Vazeux; D Canioni; T Potter; W M Gallatin; N Brousse
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

7.  Cloning and characterization of a new intercellular adhesion molecule ICAM-R.

Authors:  R Vazeux; P A Hoffman; J K Tomita; E S Dickinson; R L Jasman; T St John; W M Gallatin
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

8.  Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury.

Authors:  S G Soriano; S A Lipton; Y F Wang; M Xiao; T A Springer; J C Gutierrez-Ramos; P R Hickey
Journal:  Ann Neurol       Date:  1996-05       Impact factor: 10.422

9.  Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B.

Authors:  C Rosette; M Karin
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

10.  CD50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59fyn and p56lck in Jurkat T cell line.

Authors:  M Juan; O Viñas; M R Pino-Otín; L Places; E Martínez-Cáceres; J J Barceló; A Miralles; R Vilella; M A de la Fuente; J Vives
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  26 in total

1.  Rs5498 polymorphism may be a risk factor for coronary heart disease in Chinese population: evidence from a meta-analysis involving 5537 subjects.

Authors:  Lei Cui; Shicong Jing; Xiangfen Wang; Qiang Zong; Xiao Li; Chunxiao Jiao; Lei Peng; Lin Liu; Xinmiao Xu; Mingfeng Niu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  The intercellular adhesion molecule type-1 is required for rapid activation of T helper type 1 lymphocytes that control early acute phase of genital chlamydial infection in mice.

Authors:  J U Igietseme; G A Ananaba; J Bolier; S Bowers; T Moore; T Belay; D Lyn; C M Black
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

3.  HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4+ T Cells by NK Cells.

Authors:  Scott M Sugden; Tram N Q Pham; Éric A Cohen
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Gene expression profiling of coronary artery disease and its relation with different severities.

Authors:  Shiridhar Kashyap; Sudeep Kumar; Vikas Agarwal; Durga P Misra; Shubha R Phadke; Aditya Kapoor
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

Review 5.  Intercellular adhesion molecules (ICAMs) and spermatogenesis.

Authors:  Xiang Xiao; Dolores D Mruk; C Yan Cheng
Journal:  Hum Reprod Update       Date:  2013-01-03       Impact factor: 15.610

6.  Intercellular adhesion molecule 1 gene K469E polymorphism is associated with coronary heart disease risk: a meta-analysis involving 12 studies.

Authors:  Ya-Nan Ji; Qin Wang; Ping Zhan
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

Review 7.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

8.  Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.

Authors:  Ivana Shawkatová; Juraj Javor; Zuzana Párnická; Mária Bucová; Daniela Čopíková-Cudráková; Jozef Michalík; Karin Gmitterová; Daniel Čierny; Milan Buc; Vladimíra Ďurmanová
Journal:  Folia Microbiol (Praha)       Date:  2017-01-27       Impact factor: 2.099

9.  Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1.

Authors:  Deepa Kolaseri Krishnadas; Lei Bao; Fanqi Bai; Satheesh Cheeyancheri Chencheri; Kenneth Lucas
Journal:  Tumour Biol       Date:  2014-03-02

10.  Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease.

Authors:  Beata Sarecka-Hujar; Iwona Zak; Jolanta Krauze
Journal:  Clin Exp Med       Date:  2008-12-02       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.